Homozygosity for a hypomorphic mutation in frizzled class receptor 5 causes syndromic ocular coloboma with microcornea in humans
Ocular coloboma (OC) is a congenital disorder caused by the incomplete closure of the embryonic ocular fissure. OC can present as a simple anomaly or, in more complex forms, be associated with additional ocular abnormalities. It can occur in isolation or as part of a broader syndrome, exhibiting considerable genetic heterogeneity. Diagnostic yield for OC remains below 30%, indicating the need for further genetic exploration. Mutations in the Wnt receptor FZD5, which is expressed throughout eye development, have been linked to both isolated and complex forms of coloboma. These mutations often result in a dominant-negative effect, where the mutated FZD5 protein disrupts WNT signaling by sequestering WNT ligands. Here, we describe a case of syndromic bilateral OC with additional features such as microcornea, bone developmental anomalies, and mild intellectual disability. Whole exome sequencing revealed a homozygous rare missense variant in FZD5. Consistent with a loss-of-function effect, overexpressing of fzd5 mRNA harboring the missense variant in zebrafish embryos does not influence embryonic development, whereas overexpression of wild-type fzd5 mRNA results in body axis duplications. However, in vitro TOPFlash assays revealed that the missense variant only caused partial loss-of-function, behaving as a hypomorphic mutation. We further showed that the mutant protein still localized to the cell membrane and maintained proper conformation when modeled in silico, suggesting that the impairment lies in signal transduction. This hypothesis is further supported by the fact that the variant affects a highly conserved amino acid known to be crucial for protein-protein interactions.
Authors
- Lucas Fares‐Taie (ORCID: https://orcid.org/0000-0002-4613-0711)
- Miguel Rodríguez-Morales (ORCID: https://orcid.org/0000-0002-4302-1069)
- Florencia Cavodeassi (ORCID: https://orcid.org/0000-0003-4609-6258)
- Hane Lee (ORCID: https://orcid.org/0000-0002-4736-0412)
- Julie Plaisancié (ORCID: https://orcid.org/0000-0001-7551-248X)
- Claudine Mayer (ORCID: https://orcid.org/0000-0002-6854-5846)
- Paris Ataliotis (ORCID: https://orcid.org/0000-0002-9741-6410)
- Nicolas Chassaing (ORCID: https://orcid.org/0000-0003-0234-8820)
- Jean‐Michel Rozet (ORCID: https://orcid.org/0000-0001-7951-7886)
- Vianney Cortés‐González (ORCID: https://orcid.org/0000-0001-5312-2990)
Institutions
- Inserm (FR)
- St George's, University of London (GB)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes (MX)
- Hôpital des Enfants (FR)
- Institut des Maladies Génétiques Imagine (FR)
- City St George's, University of London (GB)
- Université de Strasbourg (FR)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Human Genetics
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1007/s00439-024-02712-y
- Citations
- 3
- Primary Topic
- Ocular Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.65
Funders
- Wellcome Trust
- Institut National de la Santé et de la Recherche Médicale